These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1797600)

  • 41. Cost-effective analysis of transjugular intrahepatic portosystemic shunt versus surgical portacaval shunt for variceal bleeding in early cirrhosis.
    Pierce DS; Sperry J; Nirula R
    Am Surg; 2011 Feb; 77(2):169-73. PubMed ID: 21337874
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Calibrated side-to-side portacaval anastomosis in the treatment of bleeding from ruptured esophageal varices. Results in 38 cirrhotic patients].
    Chabert M; Page Y; Cadi F; Porcheron J; Dufraisse G; Vigne-Rebaud MA; Barral F; Balique JG
    Gastroenterol Clin Biol; 1990; 14(10):698-704. PubMed ID: 2262116
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Plasma gamma-aminobutyric acid in experimental fulminant hepatic failure of rats and its diagnostic value in hepatic encephalopathy.
    Wang F; Niu Z; Li ZM
    Chin Med J (Engl); 1990 Mar; 103(3):197-200. PubMed ID: 2114962
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Encephalopathy in patients with cirrhosis of the liver. A neuropsychological study.
    Elsass P; Lund Y; Ranek L
    Scand J Gastroenterol; 1978; 13(2):241-7. PubMed ID: 635463
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reduction of highly elevated plasma levels of gamma-aminobutyric acid does not reverse hepatic coma.
    Löscher W; Kretz FJ; Tung LC; Dillinger U
    Hepatogastroenterology; 1989 Dec; 36(6):504-5. PubMed ID: 2613172
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Several factors in the pathogenesis of hepatic failure in patients with liver cirrhosis and bleeding from esophageal and gastric varicose veins].
    Bour AV; Manuk'ian GV; Umruzakov IU; Shertsinger AG
    Anesteziol Reanimatol; 1993; (2):32-4. PubMed ID: 7943876
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Late results of portocaval shunt operation in liver cirrhosis].
    Wildhirt E
    Dtsch Z Verdau Stoffwechselkr; 1970; 30(1):115-7. PubMed ID: 5501412
    [No Abstract]   [Full Text] [Related]  

  • 48. [Calibrated latero-lateral portacaval anastomosis in the treatment of digestive hemorrhages by portal hypertension in the cirrhotic patient].
    Segol P; Auvray S; Dao T; Apoil B; Justum AM; Deshayes JP; Launoy G
    Ann Chir; 1992; 46(10):895-901. PubMed ID: 1300900
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Portal vein thrombectomy in shunt surgeries].
    Schulz D; Esser G
    Zentralbl Chir; 1970 Aug; 95(33):977-81. PubMed ID: 5316179
    [No Abstract]   [Full Text] [Related]  

  • 50. [Treatment of portal hypertension. Indications for and methods of portacaval shunt in the cirrhotic patient].
    Maillard JN; Flamant Y
    Minerva Med; 1978 Apr; 69(17):1167-70. PubMed ID: 662146
    [No Abstract]   [Full Text] [Related]  

  • 51. Results of a 12-year randomized trial of portacaval shunt in patients with alcoholic liver disease and bleeding varices.
    Reynolds TB; Donovan AJ; Mikkelsen WP; Redeker AG; Turrill FL; Weiner JM
    Gastroenterology; 1981 May; 80(5 pt 1):1005-11. PubMed ID: 7009309
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The prophylactic portacaval shunt.
    Lancet; 1972 May; 1(7758):999-1000. PubMed ID: 4112373
    [No Abstract]   [Full Text] [Related]  

  • 53. [A new therapeutic concept for the selection of liver cirrhotics with recurrent bleeding esophageal varices for selective shunt].
    Paquet KJ; Thelen M; Koischwitz G; Biersack HJ
    Chirurg; 1979 May; 50(5):313-7. PubMed ID: 313324
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Postoperative syndromes after portacaval shunt in patients with cirrhosis of the liver (author's transl)].
    Karavias T; Häring R; Weber D
    Leber Magen Darm; 1982 Apr; 12(2):85-9. PubMed ID: 7098748
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Experimental, clinical, and metabolic results of side-to-side portacaval shunt for intractable cirrhotic ascites.
    Orloff MJ; Orloff MS; Orloff SL; Girard B
    J Am Coll Surg; 1997 Jun; 184(6):557-70. PubMed ID: 9179111
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Encephalopathy developing after portacaval anastomosis].
    Nielubowiczowa H; Tarnawska S
    Neurol Neurochir Pol; 1973; 7(2):171-6. PubMed ID: 4786322
    [No Abstract]   [Full Text] [Related]  

  • 57. Clinical and portal hemodynamic features in cirrhotic patients having a large spontaneous splenorenal and/or gastrorenal shunt.
    Ohnishi K; Sato S; Saito M; Terabayashi H; Nakayama T; Saito M; Chin N; Iida S; Nomura F; Okuda K
    Am J Gastroenterol; 1986 Jun; 81(6):450-5. PubMed ID: 3518409
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bleeding varices: 2. Elective management.
    Hanna SS; Warren WD; Galambos JT; Millikan WJ
    Can Med Assoc J; 1981 Jan; 124(1):42-7. PubMed ID: 7006780
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Portal hypertension.
    Collini FJ; Brener B
    Surg Gynecol Obstet; 1990 Feb; 170(2):177-92. PubMed ID: 2405526
    [TBL] [Abstract][Full Text] [Related]  

  • 60. TIPS for prevention of recurrent bleeding in patients with cirrhosis: meta-analysis of randomized clinical trials.
    Luca A; D'Amico G; La Galla R; Midiri M; Morabito A; Pagliaro L
    Radiology; 1999 Aug; 212(2):411-21. PubMed ID: 10429698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.